Of the nine studies evaluating NHL, the study by Kanemitsu et al. [13] was a notable outlier in that it indicated a significantly more favorable prognosis in LMP1 positive patients (Figure 2). The gene discussed is PDLIM7; the disease is non-Hodgkin lymphoma.